Annals of Laboratory Medicine

  • 제38권6호
  • /
  • Pages.591-598
  • /
  • 2018
  • /
  • 2234-3806(pISSN)
  • /
  • 2234-3814(eISSN)
대한진단검사의학회 (Korean Society for Laboratory Medicine)
권호 표지
DOI QR코드

DOI QR Code

Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation

  • Nam, Minjeong (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Shin, Sue (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Park, Kyoung Un (Department of Laboratory Medicine, Seoul National University College of Medicine) ;
  • Kim, Inho (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Yoon, Sung-Soo (Department of Internal Medicine, Seoul National University College of Medicine) ;
  • Kwon, Tack-Kyun (Department of Otorhinolaryngology, Seoul National University College of Medicine) ;
  • Song, Eun Young (Department of Laboratory Medicine, Seoul National University College of Medicine)
  • 투고 : 2017.11.27
  • 심사 : 2018.06.22
  • 발행 : 2018.11.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Forkhead box P3 (FOXP3) is an important marker of regulatory T cells. FOXP3 polymorphisms are associated with autoimmune diseases, cancers, and allograft outcomes. We examined whether single nucleotide polymorphisms (SNPs) at the FOXP3 locus are associated with clinical outcomes after allogenic hematopoietic stem cell transplantation (HSCT). Methods: Five FOXP3 SNPs (rs5902434, rs3761549, rs3761548, rs2232365, and rs2280883) were analyzed by PCR-sequencing of 172 DNA samples from allogenic HSCT patients. We examined the relationship between each SNP and the occurrence of graft-versus-host disease (GVHD), post-HSCT infection, relapse, and patient survival. Results: Patients with acute GVHD (grades II-IV) showed higher frequencies of the rs3761549 T/T genotype, rs5902434 ATT/ATT genotype, and rs2232365 G/G genotype than did patients without acute GVHD (P =0.017, odds ratio [OR]=5.3; P =0.031, OR=2.4; and P =0.023, OR=2.6, respectively). Multivariate analysis showed that the TT genotype of rs3761549 was an independent risk factor for occurrence of acute GVHD (P =0.032, hazard ratio=5.6). In contrast, the genotype frequencies of rs3761549 T/T, rs5902434 ATT/ATT, and rs2232365 G/G were lower in patients with post-HSCT infection than in patients without infection (P =0.026, P =0.046, and P =0.031, respectively). Conclusions: rs3761549, rs5902434, and rs2232365 are associated with an increased risk of acute GVHD and decreased risk of post-HSCT infection.

키워드

과제정보

연구 과제 주관 기관 : National Research Foundation of Korea (NRF)

참고문헌

  1. Arnaout K, Patel N, Jain M, El-Amm J, Amro F, Tabbara IA, et al. Complications of allogeneic hematopoietic stem cell transplantation. Cancer Invest 2014;32:349-62. https://doi.org/10.3109/07357907.2014.919301
  2. Beres AJ and Drobyski WR. The role of regulatory T cells in the biology of graft versus host disease. Front Immunol 2013;4:163.
  3. Gratama JW, van Esser JW, Lamers CH, Tournay C, Lowenberg B, Bolhuis RL, et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001;98:1358-64. https://doi.org/10.1182/blood.V98.5.1358
  4. van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogenic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood 2001;98:972-8. https://doi.org/10.1182/blood.V98.4.972
  5. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133:775-87. https://doi.org/10.1016/j.cell.2008.05.009
  6. von Herrath MG and Harrison LC. Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003;3:223-32. https://doi.org/10.1038/nri1029
  7. Le NT and Chao N. Regulating regulatory T cells. Bone Marrow Transplant 2007;39:1-9. https://doi.org/10.1038/sj.bmt.1705529
  8. Elbadry MI, Noreldin AKA, Hassanein HA. After moving of regulatory T-cell therapy to the clinic: will we need a new Tregs source? Hematol Transfus Int J 2017;5:00117.
  9. Singer BD, King LS, D'Alessio FR. Regulatory T cells as immunotherapy. Front Immunol 2014;5:1-10.
  10. Curiel TJ. Regulatory T-cell development: is Foxp3 the decider? Nat Med 2007;13:250-3. https://doi.org/10.1038/nm0307-250
  11. Oda JM, Hiraata BK, Guembarovski RL, Watanabe MA. Genetic polymorphism in FOXP3 gene: imbalance in regulatory T-cell role and development of human diseases. J Genet 2013;92:163-71. https://doi.org/10.1007/s12041-013-0213-7
  12. Marques CR, Costa RS, Costa GNO, da Silva TM, Teixeira TO, de Andrade EMM, et al. Genetic and epigenetic studies of FOXP3 in asthma and allergy. Asthma Res Pract 2015;1:10. https://doi.org/10.1186/s40733-015-0012-4
  13. Chen X, Gan T, Liao Z, Chen S, Xiao J. Foxp3 (-/ATT) polymorphism contributes to the susceptibility of preeclampsia. PLoS One 2013;8:e59696. https://doi.org/10.1371/journal.pone.0059696
  14. Lin YC, Lee JH, Wu AS, Tsai CY, Yu HH, Wang LC, et al. Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study. Lupus 2011;20:137-43. https://doi.org/10.1177/0961203310382428
  15. Bossowski A, Borysewicz-Sanczyk H, Wawrusiewicz-Kurylonek N, Zasim A, Szalecki M, Wikiera B, et al. Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases. Autoimmunity 2014;47:395-400. https://doi.org/10.3109/08916934.2014.910767
  16. Fazelzadeh Haghighi M, Ali Ghayumi M, Behzadnia F, Erfani N. Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma. Iran J Basic Med Sci 2015;18:465-71.
  17. Jiang LL and Ruan LW. Association between FOXP3 promoter polymorphisms and cancer risk: a meta-analysis. Oncol Lett 2014;8:2795-9. https://doi.org/10.3892/ol.2014.2585
  18. Mojtahedi Z, Erfani N, Haghshenas MR, Hosseini SV, Ghaderi A. Association of FoxP3/Scurfin germline polymorphism (C-2383T/rs3761549) with colorectal cancer. Ann Colorectal Res 2013;1:12-6. https://doi.org/10.17795/acr-11478
  19. Qiu XY, Jiao Z, Zhang M, Chen JP, Shi XJ, Zhong MK. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients. Nephrology (Carlton) 2012;17:423-30. https://doi.org/10.1111/j.1440-1797.2012.01561.x
  20. Misra MK, Mishra A, Pandey SK, Kapoor R, Sharma RK, Agrawal S. Association of functional genetic variants of transcription factor Forkhead Box P3 and Nuclear Factor-${\kappa}B$ with end-stage renal disease and renal allograft outcome. Gene 2016;581:57-65. https://doi.org/10.1016/j.gene.2016.01.028
  21. Engela AU, Boer K, Roodnat JI, Peeters AM, Eilers PH, Kal-van Gestel JA, et al. Genetic variants of FOXP3 influence graft survival in kidney transplant patients. Hum Immunol 2013;74:751-7. https://doi.org/10.1016/j.humimm.2013.02.008
  22. Song EY, Park MH, Kang SJ, Park HJ, Kim BC, Tokunaga K, et al. HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens 2002;59:475-86. https://doi.org/10.1034/j.1399-0039.2002.590604.x
  23. Piao Z, Kim HJ, Choi JY, Hong CR, Lee JW, Kang HJ, et al. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients. Int Immunopharmacol 2016;31:132-9. https://doi.org/10.1016/j.intimp.2015.12.022
  24. Gratwohl A. The EBMT risk score. Bone Marrow Transplant 2012;47: 749-56. https://doi.org/10.1038/bmt.2011.110
  25. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
  26. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11:945-56. https://doi.org/10.1016/j.bbmt.2005.09.004
  27. Barbosa CP, Teles JS, Lerner TG, Peluso C, Mafra FA, Vilarino FL, et al. Genetic association study of polymorphisms FOXP3 and FCRL3 in women with endometriosis. Fertil Steril 2012;97:1124-8. https://doi.org/10.1016/j.fertnstert.2012.01.125
  28. Andre GM, Barbosa CP, Teles JS, Vilarino FL, Christofolini DM, Bianco B, et al. Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. Fertil Steril 2011;95:2223-7. https://doi.org/10.1016/j.fertnstert.2011.03.033
  29. Wu Z, You Z, Zhang C, Li Z, Su X, Zhang X, et al. Association between functional polymorphisms of Foxp3 gene and the occurrence of unexplained recurrent spontaneous abortion in a Chinese Han population. Clin Dev Immunol 2012;2012:896458.
  30. Gao L, Li K, Li F, Li H, Liu L, Wang L, et al. Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients. J Dermatol Sci 2010; 57:51-6. https://doi.org/10.1016/j.jdermsci.2009.09.010
  31. Chekmenev DS, Haid C, Kel AE. P-Match: transcription factor binding site search by combining pattern and weight matrices. Nucleic Acids Res 2005;1:432-7.
  32. Chou C, Pinto AK, Curtis JD, Persaud SP, Cella M, Lin CC, et al. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nat Immunol 2014;15:884-93. https://doi.org/10.1038/ni.2943
  33. Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, et al. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 2005;106:2903-11. https://doi.org/10.1182/blood-2005-03-1257
  34. Mittrucker HW, Kaufmann SH. Mini-review: regulatory T cells and infection: suppression revisited. Eur J Immunol 2004;34:306-12. https://doi.org/10.1002/eji.200324578
  35. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007;7:875-88. https://doi.org/10.1038/nri2189
  36. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004;4:841-55. https://doi.org/10.1038/nri1485
  37. Belkaid Y and Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-60.
  38. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004;78: 2454-9. https://doi.org/10.1128/JVI.78.5.2454-2459.2004
  39. Fernandez-Ruiz M, Corrales I, Arias M, Campistol JM, Gimenez E, Crespo J, et al. Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant recipients. Am J Transplant 2015;15:1323-35. https://doi.org/10.1111/ajt.13107
  40. Manuel O, Wojtowicz A, Bibert S, Mueller NJ, van Delden C, Hirsch HH, et al. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis 2015;211:906-14. https://doi.org/10.1093/infdis/jiu557

피인용 문헌

  1. The Role of Forkhead Box Proteins in Acute Myeloid Leukemia vol.11, pp.6, 2019, https://doi.org/10.3390/cancers11060865
  2. Delayed NK Cell Reconstitution and Reduced NK Activity Increased the Risks of CMV Disease in Allogeneic-Hematopoietic Stem Cell Transplantation vol.21, pp.10, 2020, https://doi.org/10.3390/ijms21103663